Across healthcare, AI has moved from experimentation to enterprise execution. CDO Magazine recognizes the Top 30 Healthcare Innovators 2026 who are turning that shift into measurable impact.

This year’s honorees lead at the highest levels of data, analytics, and AI across Fortune 500 and equivalent-scale healthcare organizations in North America. Representing industry leaders such as UnitedHealthcare, CVS Health, Johnson & Johnson, Roche, Merck, Eli Lilly, Mayo Clinic, and MD Anderson Cancer Center, they are driving transformation across the full healthcare ecosystem — payers, providers, life sciences, and medtech.

This is not a list of titles. It is a list of innovative operators at scale. Chief Data & Analytics Officers, Chief AI Officers, Chief Information & Digital Officers, and senior executives accountable for multi-billion-dollar data and AI portfolios and enterprise-wide transformation.

Their work reflects a clear transition beyond pilots. These leaders are industrializing AI across the enterprise, modernizing global data platforms, and embedding intelligence into clinical, research, and operational workflows. The outcomes are measurable, tied to revenue growth, cost efficiency, care quality, and patient impact.

“The leaders recognized in this year’s Top 30 Healthcare Innovators list are defining what execution at scale looks like in healthcare,” says Molly Baab, CDO Magazine Chief Operating Officer. “They are embedding data and AI into the core of how organizations operate and deliver value, with accountability tied directly to outcomes.”

From AI-driven drug discovery and clinical development to real-time care delivery and population health, the 2026 cohort is redefining how healthcare organizations operate and compete.

Join us in celebrating the Top 30 Healthcare Innovators 2026 and explore the full list of honorees building the future of healthcare.